Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Sep 1;155(9):1005-1006.
doi: 10.1001/jamadermatol.2019.1105.

A Call to Accelerate Hidradenitis Suppurativa Research and Improve Care-Moving Beyond Burden

Haley B Naik  1 , Michelle A Lowes  2
Affiliations

A Call to Accelerate Hidradenitis Suppurativa Research and Improve Care-Moving Beyond Burden

Haley B Naik et al. JAMA Dermatol. .
No abstract available

PubMed Disclaimer

Figures

Figure.
Figure.. Publications and National Institutes of Health (NIH) Support for Hidradenitis Suppurativa (HS) vs Other Dermatologic Conditions
A, Number of annual PubMed citations for HS lags behind that of other prevalent and rare immune-mediated skin diseases (1945-2018), search date January 31, 2019. B, NIH has awarded 9 grants for HS research totaling $865321, including 2 career development awards, 1 R03 research grant, and intramural research programs. By comparison, 4443 grants for psoriasis research totaled $1.42 billion in NIH funds. The National Institute of Arthritis and Musculoskeletal and Skin Diseases has now developed funding opportunities specifically for HS (PA-18-718 and PA-18-719). Total cumulative NIH funds awarded for 6 immune-mediated skin diseases research determined by NIH RePORTER database, search date February 4, 2019.
See this image and copyright information in PMC

Comment in

References

    1. Alavi A, Anooshirvani N, Kim WB, Coutts P, Sibbald RG. Quality-of-life impairment in patients with hidradenitis suppurativa: a Canadian study. Am J Clin Dermatol. 2015;16(1):61–65. doi:10.1007/s40257-014-0105-5 - DOI - PubMed
    1. Garg A, Kirby JS, Lavian J, Lin G, Strunk A. Sex- and age-adjusted population analysis of prevalence estimates for hidradenitis suppurativa in the United States. JAMA Dermatol. 2017;153(8): 760–764. doi:10.1001/jamadermatol.2017.0201 - DOI - PMC - PubMed
    1. Ingram JR, Jenkins-Jones S, Knipe DW, Morgan CLI, Cannings-John R, Piguet V. Population-based Clinical Practice Research Datalink study using algorithm modelling to identify the true burden of hidradenitis suppurativa. Br J Dermatol. 2018;178(4):917–924. doi:10.1111/bjd.16101 - DOI - PubMed
    1. Lewis V, Finlay AY. 10 years experience of the Dermatology Life Quality Index (DLQI). J Investig Dermatol Symp Proc. 2004;9(2):169–180. doi:10.1111/j.1087-0024.2004.09113.x - DOI - PubMed
    1. Tamási B, Brodszky V, Péntek M, et al. Validity of the EQ-5D in patients with pemphigus vulgaris and pemphigus foliaceus. Br J Dermatol. 2019;180(4): 802–809. doi:10.1111/bjd.16883 - DOI - PubMed